she felt sick for 2 days/After 1st booster dose caller experienced same symptoms than with 2nd shot; more chills / After 1st booster dose caller experienced same symptoms than with 2nd shot; severe illness/ After 1st booster dose caller experienced same symptoms than with 2nd shot, but severe illness for 3 days; severe sweating / After 1st booster dose caller experienced same symptoms than with 2nd shot; patient felt a lot of cold / After 1st booster dose caller experienced same symptoms than with 2nd shot; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (severe illness/ After 1st booster dose caller experienced same symptoms than with 2nd shot, but severe illness for 3 days), HYPERHIDROSIS (severe sweating / After 1st booster dose caller experienced same symptoms than with 2nd shot), NASOPHARYNGITIS (patient felt a lot of cold / After 1st booster dose caller experienced same symptoms than with 2nd shot), MALAISE (she felt sick for 2 days/After 1st booster dose caller experienced same symptoms than with 2nd shot) and CHILLS (more chills / After 1st booster dose caller experienced same symptoms than with 2nd shot) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038O21A, 012M20A and 041L20A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Allergic to Morphine), Latex allergy, Cardiac disorder and Atrial fibrillation since 2018. Concomitant products included APIXABAN (ELIQUIS), METOPROLOL, AMIODARONE, ZINC and COLECALCIFEROL (VITAMIN D3) for an unknown indication.   On 01-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Oct-2021, the patient experienced ILLNESS (severe illness/ After 1st booster dose caller experienced same symptoms than with 2nd shot, but severe illness for 3 days), HYPERHIDROSIS (severe sweating / After 1st booster dose caller experienced same symptoms than with 2nd shot), NASOPHARYNGITIS (patient felt a lot of cold / After 1st booster dose caller experienced same symptoms than with 2nd shot) and CHILLS (more chills / After 1st booster dose caller experienced same symptoms than with 2nd shot). On an unknown date, the patient experienced MALAISE (she felt sick for 2 days/After 1st booster dose caller experienced same symptoms than with 2nd shot). On 27-Oct-2021, ILLNESS (severe illness/ After 1st booster dose caller experienced same symptoms than with 2nd shot, but severe illness for 3 days), HYPERHIDROSIS (severe sweating / After 1st booster dose caller experienced same symptoms than with 2nd shot), NASOPHARYNGITIS (patient felt a lot of cold / After 1st booster dose caller experienced same symptoms than with 2nd shot) and CHILLS (more chills / After 1st booster dose caller experienced same symptoms than with 2nd shot) had resolved. At the time of the report, MALAISE (she felt sick for 2 days/After 1st booster dose caller experienced same symptoms than with 2nd shot) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Oct-2021, Antibody test: 250 units per ml, greater than the normal range. (High) 250 units per mL, greater than the normal range..     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient informed she got an antibody test on the same day previous to get her 1st booster shot, and it was 250 units per mL, greater than the normal range. Patient was wondering and hesitating if she should get 2nd booster shot, because she did not want to have more severe symptoms, and she was concern it could be due to her cardiac issues, or if maybe she could have a cytokine storm.  No treatment was given to the patient.   This case was linked to MOD-2022-542338, MOD-2022-542337 (Patient Link).